Jessica M Snyder

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersToxicology (incl. clinical toxicology)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2026
Investigation of an ALDH1A1-Specific Inhibitor, FSI-TN42, as a Treatment for Obesity in Female Mice.

|Jun 30, 2026
Spontaneous rhabdomyosarcomas in Dmdmdx rats.

|Jul 02, 2025
End-of-life pathology in UM-HET3 mice treated with 16 α‑hydroxyestradiol or late‑start canagliflozin.

Jessica M Snyder, David E Harrison, Ron Korstanje

|Feb 14, 2025
Fluoxetine promotes IL-10-dependent metabolic defenses to protect from sepsis-induced lethality.

Robert M Gallant, Karina K Sanchez, Emeline Joulia

|Dec 09, 2024
Repeated administration of pharmaceutical-grade medium chain triglycerides, a common pharmacologic excipient, confers dose-dependent toxicity by the intraperitoneal but not oral route in mice.

Mitzi Adler-Wachter, Julia Y Tsai, Brendan N Schweitzer

|Feb 08, 2022
Perfusion with 10% neutral-buffered formalin is equivalent to 4% paraformaldehyde for histopathology and immunohistochemistry in a mouse model of experimental autoimmune encephalomyelitis.

Jessica M Snyder, Enrico Radaelli, Adam Goeken

Pageof 2

Frequent Collaborators

1 joint publications

Kathryn McGuckin Wuertz

1 joint publications

Piper M Treuting

1 joint publications

Emily A Hemann

1 joint publications

Annelise G Snyder